vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and Perella Weinberg Partners (PWP). Click either name above to swap in a different company.
Perella Weinberg Partners is the larger business by last-quarter revenue ($219.2M vs $123.8M, roughly 1.8× NATURES SUNSHINE PRODUCTS INC). Perella Weinberg Partners runs the higher net margin — 6.3% vs 3.3%, a 3.0% gap on every dollar of revenue. On growth, NATURES SUNSHINE PRODUCTS INC posted the faster year-over-year revenue change (4.7% vs -2.9%). Perella Weinberg Partners produced more free cash flow last quarter ($30.5M vs $7.6M). Over the past eight quarters, Perella Weinberg Partners's revenue compounded faster (46.5% CAGR vs 5.6%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
PJT Partners, Inc. is a global advisory-focused investment bank, founded in October 2015 as part of The Blackstone Group's spin-off of its financial and strategic advisory services businesses.
NATR vs PWP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $219.2M |
| Net Profit | $4.1M | $13.8M |
| Gross Margin | 72.5% | — |
| Operating Margin | 4.3% | 8.5% |
| Net Margin | 3.3% | 6.3% |
| Revenue YoY | 4.7% | -2.9% |
| Net Profit YoY | 1379.4% | — |
| EPS (diluted) | $0.23 | $0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $219.2M | ||
| Q3 25 | $128.3M | $164.6M | ||
| Q2 25 | $114.8M | $155.3M | ||
| Q1 25 | $113.2M | $211.8M | ||
| Q4 24 | $118.2M | $225.7M | ||
| Q3 24 | $114.6M | $278.2M | ||
| Q2 24 | $110.6M | $272.0M | ||
| Q1 24 | $111.0M | $102.1M |
| Q4 25 | $4.1M | $13.8M | ||
| Q3 25 | $5.3M | $6.0M | ||
| Q2 25 | $5.3M | $2.7M | ||
| Q1 25 | $4.7M | $17.3M | ||
| Q4 24 | $-321.0K | — | ||
| Q3 24 | $4.3M | $16.4M | ||
| Q2 24 | $1.3M | $-66.0M | ||
| Q1 24 | $2.3M | $-35.8M |
| Q4 25 | 72.5% | — | ||
| Q3 25 | 73.3% | — | ||
| Q2 25 | 71.7% | — | ||
| Q1 25 | 72.1% | — | ||
| Q4 24 | 72.0% | — | ||
| Q3 24 | 71.3% | — | ||
| Q2 24 | 71.4% | — | ||
| Q1 24 | 71.2% | — |
| Q4 25 | 4.3% | 8.5% | ||
| Q3 25 | 7.0% | 5.4% | ||
| Q2 25 | 3.7% | 5.8% | ||
| Q1 25 | 5.4% | 5.5% | ||
| Q4 24 | 3.8% | — | ||
| Q3 24 | 4.6% | 12.9% | ||
| Q2 24 | 5.1% | -30.2% | ||
| Q1 24 | 4.2% | -52.4% |
| Q4 25 | 3.3% | 6.3% | ||
| Q3 25 | 4.2% | 3.6% | ||
| Q2 25 | 4.6% | 1.8% | ||
| Q1 25 | 4.2% | 8.2% | ||
| Q4 24 | -0.3% | — | ||
| Q3 24 | 3.8% | 5.9% | ||
| Q2 24 | 1.2% | -24.3% | ||
| Q1 24 | 2.1% | -35.1% |
| Q4 25 | $0.23 | $0.11 | ||
| Q3 25 | $0.30 | $0.08 | ||
| Q2 25 | $0.28 | $0.04 | ||
| Q1 25 | $0.25 | $0.24 | ||
| Q4 24 | $-0.02 | — | ||
| Q3 24 | $0.23 | $0.24 | ||
| Q2 24 | $0.07 | $-1.21 | ||
| Q1 24 | $0.12 | $-0.91 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $255.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $161.6M | $-127.4M |
| Total Assets | $261.1M | $797.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $255.9M | ||
| Q3 25 | $95.6M | $185.5M | ||
| Q2 25 | $81.3M | $145.0M | ||
| Q1 25 | $86.5M | $111.2M | ||
| Q4 24 | $84.7M | $407.4M | ||
| Q3 24 | $78.7M | $335.1M | ||
| Q2 24 | $68.7M | $185.3M | ||
| Q1 24 | $77.8M | $156.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | — |
| Q4 25 | $161.6M | $-127.4M | ||
| Q3 25 | $166.7M | $-302.4M | ||
| Q2 25 | $163.7M | $-318.4M | ||
| Q1 25 | $167.1M | $-323.1M | ||
| Q4 24 | $161.0M | $-421.4M | ||
| Q3 24 | $162.6M | $-360.8M | ||
| Q2 24 | $156.4M | $-283.0M | ||
| Q1 24 | $159.7M | $161.9M |
| Q4 25 | $261.1M | $797.6M | ||
| Q3 25 | $264.8M | $650.2M | ||
| Q2 25 | $254.9M | $606.7M | ||
| Q1 25 | $252.7M | $570.5M | ||
| Q4 24 | $240.9M | $876.8M | ||
| Q3 24 | $245.3M | $810.9M | ||
| Q2 24 | $235.8M | $645.5M | ||
| Q1 24 | $247.3M | $583.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $34.8M |
| Free Cash FlowOCF − Capex | $7.6M | $30.5M |
| FCF MarginFCF / Revenue | 6.1% | 13.9% |
| Capex IntensityCapex / Revenue | 1.9% | 2.0% |
| Cash ConversionOCF / Net Profit | 2.41× | 2.52× |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $-34.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $34.8M | ||
| Q3 25 | $18.5M | $59.2M | ||
| Q2 25 | $4.3M | $56.1M | ||
| Q1 25 | $2.6M | $-176.5M | ||
| Q4 24 | $12.2M | $223.4M | ||
| Q3 24 | $9.6M | $200.3M | ||
| Q2 24 | $1.3M | $90.0M | ||
| Q1 24 | $2.2M | $-206.3M |
| Q4 25 | $7.6M | $30.5M | ||
| Q3 25 | $16.8M | $57.6M | ||
| Q2 25 | $3.0M | $55.3M | ||
| Q1 25 | $1.5M | $-177.6M | ||
| Q4 24 | $10.0M | $207.0M | ||
| Q3 24 | $7.9M | $199.3M | ||
| Q2 24 | $-2.0M | $83.7M | ||
| Q1 24 | $-1.5M | $-214.8M |
| Q4 25 | 6.1% | 13.9% | ||
| Q3 25 | 13.1% | 35.0% | ||
| Q2 25 | 2.6% | 35.6% | ||
| Q1 25 | 1.3% | -83.8% | ||
| Q4 24 | 8.5% | 91.7% | ||
| Q3 24 | 6.9% | 71.6% | ||
| Q2 24 | -1.9% | 30.8% | ||
| Q1 24 | -1.4% | -210.3% |
| Q4 25 | 1.9% | 2.0% | ||
| Q3 25 | 1.3% | 0.9% | ||
| Q2 25 | 1.2% | 0.5% | ||
| Q1 25 | 1.0% | 0.5% | ||
| Q4 24 | 1.9% | 7.3% | ||
| Q3 24 | 1.5% | 0.4% | ||
| Q2 24 | 3.0% | 2.3% | ||
| Q1 24 | 3.3% | 8.3% |
| Q4 25 | 2.41× | 2.52× | ||
| Q3 25 | 3.46× | 9.85× | ||
| Q2 25 | 0.81× | 20.50× | ||
| Q1 25 | 0.55× | -10.18× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.21× | 12.23× | ||
| Q2 24 | 0.97× | — | ||
| Q1 24 | 0.94× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
PWP
Segment breakdown not available.
